Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew I. Koven currently holds 21,339 shares of Kala Pharmaceuticals, Inc. (KALA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew I. Koven has been a net seller of KALA stock. They have purchased $300.5K and sold $5.0M worth of shares.
Andrew I. Koven's most recent insider trade was on Jun 8, 2026, when they sold 17,186 shares at $0.00 per share.
Andrew I. Koven serves as Executive at Kala Pharmaceuticals, Inc. (KALA). They have executed 51 insider transactions totaling $5.3M over their tenure at the company.
Andrew I. Koven holds the position of Executive at Kala Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
Andrew I. Koven has shown a selling trading pattern, with $300.5K in total purchases and $5.0M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew I. Koven was on Nov 21, 2014, when they sold $4.5M worth of AUXL shares. This transaction involved 134,375 shares at $33.43 per share.
Andrew I. Koven currently owns 21,339 shares of Kala Pharmaceuticals, Inc. (KALA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew I. Koven's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew I. Koven has 51 Form 4 filings on record as an insider at Kala Pharmaceuticals, Inc..
Set alerts for Andrew I. Koven and 40,000+ other insiders.